Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
about
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewRecent advances in the development of vaccines for tuberculosisSafety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsGlobal Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.From AIDS to TB vaccines--A career in infectious diseases and translational vaccinology.Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
P2860
Q26700078-CE96F052-8BE6-410E-8E2D-62FAEF2E588EQ26796440-6D0A24C6-9800-4DD7-8B3B-F4A905A30BAFQ34663035-6CDD3140-D187-47A7-A231-054D9984622AQ35826779-FF44C275-4B48-457C-A855-74D283E15976Q38907507-E3EE57DE-5B24-435B-A887-91941FEF140CQ40914004-C5965AAB-CAF7-45D1-8B5B-1B2A2B5A5C19Q47613899-09E8310C-3F87-4A75-AABF-C2ACB3E36E4B
P2860
Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@ast
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@en
Two doses of candidate TB vaccine MVA85A in antiretroviral therapy
@nl
type
label
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@ast
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@en
Two doses of candidate TB vaccine MVA85A in antiretroviral therapy
@nl
prefLabel
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@ast
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@en
Two doses of candidate TB vaccine MVA85A in antiretroviral therapy
@nl
P2093
P2860
P1433
P1476
Two doses of candidate TB vacc ...... to one dose in ART+ subjects.
@en
P2093
Alle B Dieng
Birahim P Ndiaye
Coumba Toure-Kane
Halimatou Diop-Ndiaye
Makhtar Camara
Marema Fall
Nathaniel Brittain
Ndeye Fatou Ngom-Gueye
Papa A Diaw
Papa S Sow
P2860
P304
P356
10.1371/JOURNAL.PONE.0067177
P407
P577
2013-06-28T00:00:00Z